Clinical Trial Update: Alternative Dosing And Prevention of Transfusions (ADAPT) [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 clinical trial (ADAPT) at Cincinnati Children's Hospital evaluating alternative dosing and prevention of transfusions in sickle cell disease; stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Sickle Cell Disease | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING